ACA
LLY icon

Aspire Capital Advisors’s Eli Lilly LLY Stock Holding History

Aspire Capital Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$676K Buy
563
+25
+5% +$25.5K 0.13% 72
2026
Q1 		$495K Buy
538
+11
+2% +$11.2K 0.11% 72
2025
Q4 		$566K Buy
527
+17
+3% +$16.3K 0.13% 67
2025
Q3 		$389K Buy
510
+32
+7% +$23.8K 0.1% 78
2025
Q2 		$372K Sell
478
-156
-25% -$121K 0.1% 76
2025
Q1 		$524K Buy
634
+1
+0.2% +$832 0.16% 56
2024
Q4 		$489K Buy
633
+160
+34% +$132K 0.14% 53
2024
Q3 		$419K Buy
473
+30
+7% +$27K 0.12% 54
2024
Q2 		$402K Buy
443
+12
+3% +$9.6K 0.13% 48
2024
Q1 		$336K Buy
431
+28
+7% +$19.9K 0.11% 57
2023
Q4 		$235K Hold
403
– – 0.1% 60
2023
Q3 		$216K Buy
+403
New +$208K 0.1% 62

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aspire Capital Advisors's LLY Position: Q2 2026 in Review

Aspire Capital Advisors increased its Eli Lilly (LLY) stake by 4.6% in Q2 2026, buying an estimated $25.5K and bringing the position to 563 shares worth $676K. The position accounts for 0.13% of the portfolio, ranked #72.

Aspire Capital Advisors first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Aspire Capital Advisors held 563 shares of Eli Lilly worth $676K as of Q2 2026.
  • Aspire Capital Advisors bought 25 Eli Lilly shares in Q2 2026, an estimated $25.5K.
  • Eli Lilly made up 0.13% of Aspire Capital Advisors's portfolio in Q2 2026, its #72 holding.
  • Aspire Capital Advisors first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Aspire Capital Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.